Publikationen in Zusammenarbeit mit Forschern von Universidade da Coruña (19)

2023

  1. The CARBA-MAP study: national mapping of carbapenemases in Spain (2014–2018)

    Frontiers in Microbiology, Vol. 14

2022

  1. Aspergillus endocarditis in the recent years, report of cases of a multicentric national cohort and literature review

    Mycoses, Vol. 65, Núm. 3, pp. 362-373

  2. Dalbavancin in clinical practice in Spain: A 2 year retrospective study

    JAC-Antimicrobial Resistance, Vol. 4, Núm. 6

  3. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1452-1460

2021

  1. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals

    Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076

  2. Dalbavancin in the treatment of different gram-positive infections: a real-life experience

    International Journal of Antimicrobial Agents, Vol. 51, Núm. 4, pp. 571-577

  3. Detection of spleen, kidney and liver infarcts by abdominal computed tomography does not affect the outcome in patients with left-side infective endocarditis

    Medicine (United States), Vol. 97, Núm. 33

  4. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

  5. Risk factors of pericardial effusion in native valve infective endocarditis and its influence on outcome: A multicenter prospective cohort study

    International Journal of Cardiology, Vol. 273, pp. 193-198

2017

  1. Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort

    Medicine (United States), Vol. 96, Núm. 38

2016

  1. 2016 Expert consensus document on prevention, diagnosis and treatment of short-term peripheral venous catheter-related infections in adults

    Cirugia Cardiovascular, Vol. 23, Núm. 4, pp. 192-198

  2. Endocarditis in patients with ascending aortic prosthetic graft: A case series from a national multicentre registry

    European Journal of Cardio-thoracic Surgery, Vol. 50, Núm. 6, pp. 1149-1157

  3. Infective endocarditis in hypertrophic cardiomyopathy

    Medicine (United States), Vol. 95, Núm. 26

  4. Infective endocarditis: Absence of microbiological diagnosis is an independent predictor of inhospital mortality

    International Journal of Cardiology, Vol. 220, pp. 162-165

2015

  1. Current epidemiology and outcome of infective endocarditis: A multicenter, prospective, cohort study

    Medicine (United States), Vol. 94, Núm. 43

  2. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

2011

  1. Profilaxis de la infección por citomegalovirus en el trasplante de corazón

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL.6, pp. 52-55